- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-189/13: Judgment of the General Court of 11 December 2014 — PP Nature-Balance Lizenz v Commission (Medicinal products for human use — Active substance tolperisone — Article 116 of Directive 2001/83/EC — Commission decision ordering the Member States to vary the national marketing authorisations for medicinal products for human use containing the active substance at issue — Burden of proof — Proportionality)
ECLI:EU:UNKNOWN:62013TA0189
62013TA0189
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C 34/36
(Case T-189/13)(1)
((Medicinal products for human use - Active substance tolperisone - Article 116 of Directive 2001/83/EC - Commission decision ordering the Member States to vary the national marketing authorisations for medicinal products for human use containing the active substance at issue - Burden of proof - Proportionality))
(2015/C 034/41)
Language of the case: German
Parties
Applicant: PP Nature-Balance Lizenz GmbH (Hamburg, Germany) (represented by: M. Ambrosius, lawyer)
Defendant: European Commission (represented by: initially B. R. Killmann and M. Šimerdová, then B. R. Killmann and A. Sipos, acting as Agents)
Re:
Application for partial annulment of Commission Implementing Decision C(2013) 369 (final) of 21 January 2013 concerning, in the framework of Article 31 of Directive 2001/83/EC of the European Parliament and of the Council, the marketing authorisations for the medicinal products for human use which contain the active substance ‘tolperisone’
Operative part of the judgment
The Court:
1.Dismisses the action;
2.Orders PP Nature-Balance Lizenz GmbH to bear its own costs and those incurred by the European Commission.
(1)
OJ C 164, 8.6.2103.